Browse by Hotbed/Location
Filter News
Found 483,187 articles
-
Roche and privately-held cell therapy company SQZ will jointly develop oncology products based on antigen presenting cells (APCs) that are created by the SQZ platform.
-
BioSpace Movers and Shakers for Oct. 15
10/15/2018
Who mixed things up in the biotech world this past week? Pfizer announces its leadership team, Rheos gets a new COO, and board of directors updates from multiple biopharma companies. -
Berkeley Lights calls itself a digital cell biology company. It develops and markets tech platforms for what it calls “the intersection of biology, technology and information.”
-
The U.S. Food and Drug Administration’s Anesthetic and Analgesic Drug Products Advisory Committee voted to recommend AcelRx Pharmaceuticals’ Dsuvia to manage moderate-to-severe pain.
-
Depression Awareness Month: Ketamine Clinics Put Not-Always Flattering Spotlight on Treatment
10/15/2018
Depression affects almost 20 million Americans yearly and major depressive disorders affect nearly 300 million people worldwide. The annual market for these disorders is approximately $83 billion. -
NIH Awards Grant to Battle Sepsis to San Diego's Allele Biotechnology and Pharmaceuticals
10/15/2018
The National Institute of General Medical Sciences, part of the National Institutes of Health, awarded Allele Biotechnology and Pharmaceuticals a Small Business Innovative Research grant to develop therapies for sepsis. -
Harvard Medical School and Brigham and Women’s Hospital are leading the call to remove the papers from the lab of Dr. Piero Anversa, a pioneer in the field of cardiac research.
-
China’s Innovent Biologics reportedly is continuing with its plans to raise $423 million in its Hong Kong IPO. If so, it would be the biggest biotech IPO out of Hong Kong this year.
-
Study Reveals Hidden (Potentially Dangerous) Pharmaceuticals May Be Found in OTC Supplements
10/15/2018
A new study published Friday in JAMA reports that many dietary supplements consumed by people in the United States contain unapproved pharmaceutical ingredients in the over-the-counter products that pose a health risk for unsuspecting consumers. -
Chugai Presents Results from Phase III Study of Satralizumab in NMOSD at ECTRIMS 2018
10/15/2018
Satralizumab added to baseline therapy significantly reduced risk of relapse
-
FSD Pharma and SciCann Therapeutics to Attend the CannX International Medical Cannabis Convention in Tel Aviv Israel
10/15/2018
FSD Pharma Inc. is pleased to announce that its Head of Scientific Advisory Board, Dr. Zohar Koren, will attend the 3rd International Medical Cannabis Conference, ("CannX") in Tel Aviv, Israel from October 14 to 16, 2018.
-
Therap's Dashboard Analytics Tool Offers Aggregate Health Care Data Insight for Improved Health Outcomes
10/15/2018
Therap's business intelligence tool for statistical data analysis now features a health dashboard for tracking data and analyzing an individual's health status and progress.
-
PhRMA Members Take New Approach to DTC Television Advertising
10/15/2018
To help patients make more informed health care decisions, Pharmaceutical Research and Manufacturers of America (PhRMA) member companies today announced their commitment to providing more transparency about medicine costs.
-
PellePharm Presents Updated Data from Two Phase 2 Studies Demonstrating the Potential of Patidegib Topical Gel to Treat Basal Cell Carcinomas in Patients with Gorlin Syndrome and in Patients with Non-Gorlin Sporadic BCCs
10/15/2018
PellePharm, a late clinical-stage biopharmaceutical company committed to targeting rare skin conditions at their source, today presented updated clinical data from two Phase 2 studies of patidegib topical gel in a poster session at NORD’s Rare Diseases and Orphan Products Breakthrough Summit 2018 in Washington, D.C.
-
Lilly Declares Fourth-Quarter 2018 Dividend
10/15/2018
- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2018 of $0.5625 per share on outstanding common stock
-
Advicenne Receives Health Canada Clearance to Extend its Pivotal Phase III Trial of ADV7103 in Canada
10/15/2018
Advicenne (Paris:ADVIC), a specialty pharmaceutical company focused on the development of pediatric-friendly therapeutics for the treatment of orphan renal and neurological diseases, announced today that it has received a No Objection Letter to extend its ARENA-2 pivotal Phase III trial
-
David Sinclair of Peru, VT, Wins 2018 Eversource Hartford Marathon, Rachel Schilkowsky of Providence, RI, Wins Women's Race
10/15/2018
The 25th running of the Eversource Hartford Marathon was won in 2:18:23 by David Sinclair of Peru, VT. Rachel Schilkowsky of Providence, RI, won the women's race in 2:41:03 in her first marathon, qualifying to run in the Olympic Marathon Trials.
-
Profusa Recognized by Frost & Sullivan For Innovation in the Biochemical Sensors Market
10/15/2018
Profusa, today announced it has been awarded Entrepreneurial Company of the Year in the Continuous Monitoring Biochemical Sensors Industry by Frost & Sullivan.
-
Collins Dental to host sixth annual Smiles From The Heart Free Dental Day
10/15/2018
FH Collins III, DDS and his team at Collins Dental in Winter Springs are preparing to host their sixth annual Smiles From The Heart event, which provides FREE dental care to members of the community who may have fallen on hard times.
-
Children of Catastrophically Wounded Veterans Benefit from National Program Launched Today
10/15/2018
The Independence Fund today launched a new Family program for the children of wounded Veterans and their Caregivers.